As of June 12, 2018 our Privacy Policy has been updated. For individuals in the European Union, CIL uses cookies on this website. Please review the new privacy statement to see how. By continuing to use this website you agree to us using cookies in accordance with our privacy statement. Click here for the new privacy statement..OK

Corporate Overview

IsoTopics™ – May 2020

Domain-specific quantification of prion protein in cerebrospinal fluid by targeted mass spectrometry

Minikel, E.V.; Kuhn, E.; Cocco, A.R.; et al.

Accurate and reliable quantitation of prion protein (PrP) is necessary in prion disease therapeutics. Considering the potential challenges of current quantitative methods (e.g., inability to capture protein fragments), Carr and colleagues developed an alternative approach. This involved the quantitation of PrP in cerebrospinal fluid (CSF) by bottom-up LC-MRM-MS using uniform 15N-labeled PrP (expressed using CGM-1000-N) as an internal standard for human sample analysis and 13C/15PrP tryptic peptides (synthesized using protected amino acids) for human and other species sample analyses. The metrics of the validated assay enable the selective and precise quantitation of CSF PrP and provides a basis for its clinical translation in support of on-going PrP-lowering drug studies.

Read article

Stable Isotope Newsletters | Cambridge Isotope Laboratories
stable isotope, stable isotope labeled compounds, environmental contaminant standards
CIL has been ready to help with the analytical standards critical to the task of defining and resolving any major environmental contamination problems.